CVD Equipment (CVV) 10-Q 15 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 08, 2022
Document Information [Line Items]
Entity Central Index Key	0000766792
Entity Registrant Name	CVD EQUIPMENT CORP
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	1-16525
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	11-2621692
Entity Address, Address Line One	355 South Technology Drive
Entity Address, City or Town	Central Islip
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11722
City Area Code	631
Local Phone Number	981-7081
Title of 12(b) Security	Common Stock
Trading Symbol	CVV
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,728,938

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 12,159,052	$ 16,651,371
Accounts receivable, net	2,572,192	1,446,354
Contract assets	4,255,400	2,538,373
Inventories, net	2,050,405	1,225,015
Taxes receivable	0	715,599
Other current assets	529,264	493,788
Total current assets	21,566,313	23,070,500
Property, plant and equipment, net	12,334,374	12,261,321
Intangible assets, net	205,258	182,838
Other assets	9,570	9,570
Total assets	34,115,515	35,524,229
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	1,422,072	1,161,381
Accrued expenses	1,857,317	1,758,939
Current maturities of long-term debt	0	1,765,508
Contract liabilities	3,296,062	1,650,426
Total current liabilities	6,575,451	6,336,254
Total liabilities	6,575,451	6,336,254
Stockholders’ Equity:
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,728,938 at June 30, 2022 and 6,723,438 at December 31, 2021	67,289	67,234
Additional paid-in capital	27,465,930	27,277,154
Retained earnings	6,845	1,843,587
Total stockholders’ equity	27,540,064	29,187,975
Total liabilities and stockholders’ equity	$ 34,115,515	$ 35,524,229

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	6,728,938	6,723,438
Common stock, shares outstanding (in shares)	6,728,938	6,723,438

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue	$ 5,808,588	$ 4,034,408	$ 10,460,820	$ 7,400,268
Cost of revenue	4,367,472	3,037,280	8,253,647	5,958,834
Gross profit	1,441,116	997,128	2,207,173	1,441,434
Operating expenses
Research and development	569,194	430,754	879,401	741,708
Selling and shipping	332,261	229,147	604,940	364,902
General and administrative	1,396,506	1,420,151	2,589,955	3,036,535
Total operating expenses	2,297,961	2,080,052	4,074,296	4,143,145
Operating loss	(856,845)	(1,082,924)	(1,867,123)	(2,701,711)
Other income (expense):
Interest income	12,647	403	30,929	1,626
Interest expense	0	(107,000)	(5,344)	(214,221)
Gain on debt extinguishment	0	2,443,418	0	2,443,418
Other income	5,621	217,592	5,621	436,827
Total other income, net	18,268	2,554,413	31,206	2,667,650
(Loss) income before income tax	(838,577)	1,471,489	(1,835,917)	(34,061)
Income tax expense	825	1,064	825	1,064
Net (loss) income	$ (839,402)	$ 1,470,425	$ (1,836,742)	$ (35,125)
Basic (loss) income per common share (in dollars per share)	$ (0.12)	$ 0.22	$ (0.27)	$ (0.01)
Diluted (loss) income per common share (in dollars per share)	$ (0.12)	$ 0.22	$ (0.27)	$ (0.01)
Weighted average common shares Outstanding-basic (in shares)	6,728,938	6,684,281	6,726,990	6,682,347
Weighted average common shares Outstanding-diluted (in shares)	6,728,938	6,687,229	6,726,990	6,682,347

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2020	6,678,698
Balance at Dec. 31, 2020	$ 66,786	$ 26,961,684	$ (2,902,898)	$ 24,125,572
Net income (loss)	0	0	(35,125)	(35,125)
Stock-based compensation	$ 56	112,395		112,451
Stock-based compensation (in shares)	5,583
Balance (in shares) at Jun. 30, 2021	6,684,281
Balance at Jun. 30, 2021	$ 66,842	27,074,079	(2,938,023)	24,202,898
Balance (in shares) at Mar. 31, 2021	6,684,281
Balance at Mar. 31, 2021	$ 66,842	27,012,001	(4,408,448)	22,670,395
Net income (loss)	0	0	1,470,425	1,470,425
Stock-based compensation	$ 0	62,078		62,078
Balance (in shares) at Jun. 30, 2021	6,684,281
Balance at Jun. 30, 2021	$ 66,842	27,074,079	(2,938,023)	$ 24,202,898
Balance (in shares) at Dec. 31, 2021	6,723,438			6,723,438
Balance at Dec. 31, 2021	$ 67,234	27,277,154	1,843,587	$ 29,187,975
Net income (loss)			(1,836,742)	(1,836,742)
Stock-based compensation	$ 55	188,776		$ 188,831
Stock-based compensation (in shares)	5,500
Balance (in shares) at Jun. 30, 2022	6,728,938			6,728,938
Balance at Jun. 30, 2022	$ 67,289	27,465,930	6,845	$ 27,540,064
Balance (in shares) at Mar. 31, 2022	6,728,938
Balance at Mar. 31, 2022	$ 67,289	27,374,209	846,247	28,287,745
Net income (loss)			(839,402)	(839,402)
Stock-based compensation	$ 0	91,721		$ 91,721
Balance (in shares) at Jun. 30, 2022	6,728,938			6,728,938
Balance at Jun. 30, 2022	$ 67,289	$ 27,465,930	$ 6,845	$ 27,540,064

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (1,836,742)	$ (35,125)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on debt extinguishment	0	(2,443,418)
Stock-based compensation	188,831	112,451
Depreciation and amortization	402,305	429,195
(Increase)/decrease in operating assets:
Accounts receivable	(1,125,838)	(99,723)
Contract assets	(1,717,027)	(572,101)
Inventories	(825,390)	(173,363)
Tax receivable	715,599	0
Other current assets	(35,476)	239,345
Increase/(decrease) in operating liabilities:
Accounts payable	260,691	92,798
Accrued expenses	98,378	384,654
Contract liabilities	1,645,636	214,414
Total adjustments	(392,291)	(1,815,748)
Net cash used in operating activities	(2,229,033)	(1,850,873)
Cash flows from investing activities:
Net proceeds from sale of assets	10,000	0
Capitalized patents costs	(47,423)	0
Capital expenditures	(460,355)	(118,471)
Net cash used in investing activities	(497,778)	(118,471)
Cash flows from financing activities
Payments of long-term debt	(1,765,508)	(342,095)
Net cash used in financing activities	(1,765,508)	(342,095)
Net decrease in cash and cash equivalents	(4,492,319)	(2,311,439)
Cash and cash equivalents at beginning of period	16,651,371	7,699,335
Cash and cash equivalents at end of period	12,159,052	5,387,896
Supplemental disclosure of cash flow information:
Income taxes paid	0	1,064
Interest paid	$ 8,157	$ 214,221

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	NOTE 1: BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements for CVD Equipment Corporation and Subsidiaries (collectively “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10 8 X. not not three six June 30, 2022 not December 31, 2022. The condensed consolidated balance sheet as of December 31, 2021 10 March 31, 2022, not All material intercompany balances and transactions have been eliminated in consolidation. In addition, certain reclassifications have been made to the prior period condensed consolidated financial statements to conform to the current period presentation. These reclassifications had no

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2: Revenue Recognition In accordance with FASB ASC 606 606" 606, five 1 2 3 4 5 one two Over time The Company designs, manufactures and sells custom chemical vapor deposition equipment through contractual agreements. These system sales require the Company to deliver functioning equipment that is generally completed within three eighteen “Contract assets,” include unbilled amounts typically resulting from system sales under contracts and represents revenue recognized that exceeds the amount billed to the customer. “Contract liabilities,” include advance payments and billings in excess of revenue recognized. The Company typically receives down payments upon receipt of order and progress payments as the system is manufactured. Contract assets and contract liabilities are classified as current as these contracts in progress are expected to be substantially completed within the next twelve Point in time For non-system sales of products and services, the revenue is recognized at the point in time when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606, Recent Accounting Standards In June 2016, 2016 13, 326 November 15, 2019, December 15, 2022 not The Company believes there is no not may

Note 3 - Concentration of Credi

Note 3 - Concentration of Credit Risk	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE 3: Cash and cash equivalents The Company had cash and cash equivalents of $12.2 million and $16.7 million at June 30, 2022 December 31, 2021, three June 30, 2022 December 31, 2021. The Company places most of its temporary cash investments with financial institutions, which from time to time may June 30, 2022 December 31, 2021 Sales concentration Revenue from a single customer in any one 10% three June 30, 2022, 10% six June 30, 2022 10%, three June 30, 2021, three 10% six June 30, 2021, one 10%, Accounts receivable The Company sells products and services to various companies across several industries in the ordinary course of business. The Company performs ongoing credit evaluations to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience, evaluation of their credit history and review of the invoicing terms of the contract to determine the financial strength of its customers. The Company also maintains allowances for anticipated losses. At June 30, 2022, 10% December 31, 2021 two 10%

Note 4 - Revenue Disaggregation

Note 4 - Revenue Disaggregation	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	NOTE 4: The following table represents a disaggregation of revenue for the three six June 30, 2022 2021 Three Month's Ending June 30, 2022 Over time Point in time Total Aerospace $ - $ 520 $ 520 Energy, storage and transmission 2,024 219 2,243 Industrial 1,450 725 2,175 Research 299 572 871 Total $ 3,773 $ 2,036 $ 5,809 Three Month's Ending June 30, 2021 Over time Point in time Total Aerospace $ 197 $ 577 $ 774 Energy, storage and transmission - - - Industrial 1,226 1,293 2,519 Research 365 376 741 Total $ 1,788 $ 2,246 $ 4,034 Six Month's Ending June 30, 2022 Over time Point in time Total Aerospace $ - $ 1,221 $ 1,221 Energy, storage and transmission 2,923 226 3,149 Industrial 2,446 1,597 4,043 Research 1,005 1,043 2,048 Total $ 6,374 $ 4,087 $ 10,461 Six Month's Ending June 30, 2021 Over time Point in time Total Aerospace $ 386 $ 1,102 $ 1,488 Energy, storage and transmission - - - Industrial 2,595 1,969 4,564 Research 552 796 1,348 Total $ 3,533 $ 3,867 $ 7,400 The Company has unrecognized contract revenue of approximately $12.8 million at June 30, 2022, twelve Judgment is required to evaluate assumptions including the amount of net contract revenues and the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize. Changes in estimates for sales of systems occur for a variety of reasons, including but not may Contract Assets and Liabilities During the six June 30, 2022 2021, Contract assets and contract liabilities on input method type contracts in progress are summarized as follows: 2022 Costs incurred on contracts in progress $ 8,822,284 Estimated earnings 6,151,767 14,974,051 Billings to date (13,683,261 ) $ 1,290,790 Deferred revenue related to non-systems contracts (331,452 ) 959,338 Included in accompanying balance sheets Under the following captions: Contract assets $ 4,255,400 Contract liabilities $ (3,296,062 )

Note 5 - Inventories, Net

Note 5 - Inventories, Net	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 5: Inventories consist of: June 30, 2022 December 31, 2021 Raw materials $ 1,366,405 $ 1,030,955 Work-in-process 684,000 194,060 Inventories $ 2,050,405 $ 1,225,015

Note 6 - Accounts Receivable, N

Note 6 - Accounts Receivable, Net	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 6: Accounts receivable are presented net of an allowance for doubtful accounts of approximately $36,000 and $59,000 as of June 30, 2022 December 31, 2021, may

Note 7 - Long-term Debt

Note 7 - Long-term Debt	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Long-Term Debt [Text Block]	NOTE 7: The Company had a loan agreement with HSBC which was secured by a mortgage against its Central Islip, NY Headquarters. The loan was payable in 120 consecutive equal monthly installments of $25,000 in principal plus interest and a final balloon payment upon maturity on March 1, 2022. December 31, 2021 December 31, 2021). March 1, 2022.

Note 8 - Stock-based Compensati

Note 8 - Stock-based Compensation Expense	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	NOTE 8: The Company recorded $91,721 and $188,831 during the three six June 30, 2022, three six June 30, 2021, three six June 30, 2022 2021 Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Cost of revenue $ 8,440 $ - $ 16,880 $ - Research and development 13,417 - 26,316 - Selling and shipping 5,398 - 10,796 - General and administrative 64,466 62,078 134,839 112,451 Total $ 91,721 $ 62,078 $ 188,831 $ 112,451 A summary of the stock option activity related to the 2007 2016 January 1, 2022 June 30, 2022 2007 Share Incentive Plan Beginning Granted Exercised Canceled Ending Balance During During During Balance Outstanding Period Period Period Outstanding Exercisable Number of shares 220,000 - - (25,000 ) 195,000 195,000 Weighted average exercise price per share $ 12.56 - - $ 15.00 $ 12.24 $ 12.24 2016 Share Incentive Plan Beginning Granted Exercised Canceled Ending Balance During During During Balance Outstanding Period Period Period Outstanding Exercisable Number of shares 398,500 12,500 - (6,500 ) 404,500 102,500 Weighted average exercise price per share $ 4.43 $ 4.60 - $ 4.01 $ 4.44 $ 5.33 For the six June 30, 2022, four ten six June 30, 2022 Stock Price $ 4.60 Exercise Price $ 4.60 Dividend yield 0 % Expected volatility 68 % Risk-Free interest rate 1.79 % Expected life (in years) 6.00 The Company has a total of 599,500 outstanding stock options, of which 297,500 were exercisable under the two June 30, 2022. The following table summarizes information about the outstanding and exercisable options at June 30, 2022. Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Intrinsic Number Exercise Intrinsic Price Range Outstanding Contractual Price Value Exercisable Price Value $4.00 - 7.00 384,500 8.8 $ 4.25 $ 0 82,500 $ 4.66 $ 0 $7.01 - 10.00 20,000 5.8 $ 8.07 $ 0 20,000 $ 8.07 $ 0 $10.01 - 12.00 120,000 4.7 $ 10.52 $ 0 120,000 $ 10.52 $ 0 $12.01 - 15.00 75,000 .2 $ 15.00 $ 0 75,000 $ 15.00 $ 0 No options were exercised during the six June 30, 2022. June 30, 2022, Restricted Stock Awards There were no unvested shares of restricted stock at June 30, 2022 December 31, 2021. three six June 30, 2022 Pursuant to the director compensation plan approved on October 11, 2021, may Restricted Stock Units The following table summarizes activity related to outstanding restricted stock units for the six June 30, 2022: Weighted Shares of Average Grant Restricted Date Fair Stock Units Value Unvested outstanding at December 31, 2021 5,500 $ 4.82 Granted - $ - Vested (5,500 ) $ 4.82 Forfeited/Cancelled - $ - - Unvested outstanding at June 30, 2022 - $ - The total fair value of vested restricted stock units was $3,458 for the six June 30, 2022. June 30, 2022,

Note 9 - Income Taxes

Note 9 - Income Taxes	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 9: As of June 30, 2022 December 31, 2021, two not may not On March 27, 2020, 2018 2020 five December 31, 2021. March 2022.

Note 10 - Earnings Per Share

Note 10 - Earnings Per Share	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 10: Basic earnings per share is computed by dividing net earnings available to common shareholders (the numerator) by the weighted average number of common shares outstanding (the denominator) for the period presented. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common shares had been issued. A reconciliation of basic to diluted shares used in the earnings per share calculation is as follows: Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Basic weighted average common shares outstanding 6,728,938 6,684,281 6,726,990 6,682,347 Dilutive effect of options and unvested restricted shares - 2,948 - - Diluted weighted average shares outstanding 6,728,938 6,687,229 6,726,990 6,682,347 The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three six June 30, 2022 2021, Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Stock Options 599,500 557,052 599,500 560,000 599,500 557,052 599,500 560,000 Stock options to purchase 599,500 shares of common stock were outstanding and 297,500 were exercisable during the three six June 30, 2022. The dilutive potential common shares on options is calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all options are used to repurchase common stock at market value. The number of shares remaining after the proceeds are exhausted represents the potential dilutive effect of the securities.

Note 11 - Segment Reporting

Note 11 - Segment Reporting	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 11: The Company operates through three The Company’s corporate administration activities are reported in the Eliminations and Unallocated column. These activities primarily include the elimination of intercompany sales and profit, expenses related to certain corporate officers and support staff, expenses related to the Company’s Board of Directors, stock option expense for shares granted to corporate administration employees, certain consulting expenses, investor and shareholder relations activities, and all of the Company’s legal, auditing and professional fees, and interest expense. Three Months Ended June 30, (In thousands) Eliminations* and 2022 CVD SDC Materials Unallocated Consolidated Assets $ 23,661 $ 8,474 $ 1,913 $ 68 $ 34,116 Revenue 3,782 1,591 816 (380 ) 5,809 Operating (loss) income (469 ) 227 143 (758 ) (857 ) Pretax (loss) income (451 ) 227 143 (758 ) (839 ) 2021 Assets $ 28,149 $ 6,765 $ 3,940 $ 66 $ 38,920 Revenue 1,804 1,162 1,087 (19 ) 4,034 Operating (loss) income (1,220 ) 368 503 (734 ) (1,083 ) Pretax (loss) income 1,209 368 628 (734 ) 1,471 Six Months Ended June 30, (In thousands) Eliminations* and 2022 CVD SDC Materials Unallocated Consolidated Revenue 6,607 3,006 1,273 (425 ) 10,461 Operating (loss) income (1,236 ) 670 137 (1,438 ) (1,867 ) Pretax (loss) income (1,204 ) 670 136 (1.438 ) (1,836 ) 2021 Revenue 3,811 1,987 1,716 (114 ) 7,400 Operating (loss) income (1,753 ) 363 392 (1,704 ) (2,702 ) Pretax (loss) income 661 363 646 (1,704 ) (34 ) *All elimination entries represent intersegment revenues eliminated in consolidation for external financial reporting. Intersegment sales for the three June 30, 2022 2021 $.4 $.02 six June 30, 2022 2021 $.4 $.1

Note 12 - Significant Events -

Note 12 - Significant Events - Coronavirus(COVID-19)	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Effect of Covid-19 Pandemic [Text Block]	NOTE 12: 19 The Company has been actively monitoring the coronavirus (COVID- 19 March 2020, 19 19 19 Management is unable to predict the extent of the impact the pandemic will have on the Company’s financial position and operating results for the remainder of 2022 19 The COVID- 19 may third third fourth 2021, 2022, may no may

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition In accordance with FASB ASC 606 606" 606, five 1 2 3 4 5 one two Over time The Company designs, manufactures and sells custom chemical vapor deposition equipment through contractual agreements. These system sales require the Company to deliver functioning equipment that is generally completed within three eighteen “Contract assets,” include unbilled amounts typically resulting from system sales under contracts and represents revenue recognized that exceeds the amount billed to the customer. “Contract liabilities,” include advance payments and billings in excess of revenue recognized. The Company typically receives down payments upon receipt of order and progress payments as the system is manufactured. Contract assets and contract liabilities are classified as current as these contracts in progress are expected to be substantially completed within the next twelve Point in time For non-system sales of products and services, the revenue is recognized at the point in time when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606,
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Standards In June 2016, 2016 13, 326 November 15, 2019, December 15, 2022 not The Company believes there is no not may

Note 4 - Revenue Disaggregati_2

Note 4 - Revenue Disaggregation (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Month's Ending June 30, 2022 Over time Point in time Total Aerospace $ - $ 520 $ 520 Energy, storage and transmission 2,024 219 2,243 Industrial 1,450 725 2,175 Research 299 572 871 Total $ 3,773 $ 2,036 $ 5,809 Three Month's Ending June 30, 2021 Over time Point in time Total Aerospace $ 197 $ 577 $ 774 Energy, storage and transmission - - - Industrial 1,226 1,293 2,519 Research 365 376 741 Total $ 1,788 $ 2,246 $ 4,034 Six Month's Ending June 30, 2022 Over time Point in time Total Aerospace $ - $ 1,221 $ 1,221 Energy, storage and transmission 2,923 226 3,149 Industrial 2,446 1,597 4,043 Research 1,005 1,043 2,048 Total $ 6,374 $ 4,087 $ 10,461 Six Month's Ending June 30, 2021 Over time Point in time Total Aerospace $ 386 $ 1,102 $ 1,488 Energy, storage and transmission - - - Industrial 2,595 1,969 4,564 Research 552 796 1,348 Total $ 3,533 $ 3,867 $ 7,400
Schedule Of Cost And Estimated Earnings In Excess Of Billings [Table Text Block]	2022 Costs incurred on contracts in progress $ 8,822,284 Estimated earnings 6,151,767 14,974,051 Billings to date (13,683,261 ) $ 1,290,790 Deferred revenue related to non-systems contracts (331,452 ) 959,338 Included in accompanying balance sheets Under the following captions: Contract assets $ 4,255,400 Contract liabilities $ (3,296,062 )

Note 5 - Inventories, Net (Tabl

Note 5 - Inventories, Net (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	June 30, 2022 December 31, 2021 Raw materials $ 1,366,405 $ 1,030,955 Work-in-process 684,000 194,060 Inventories $ 2,050,405 $ 1,225,015

Note 8 - Stock-based Compensa_2

Note 8 - Stock-based Compensation Expense (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Cost of revenue $ 8,440 $ - $ 16,880 $ - Research and development 13,417 - 26,316 - Selling and shipping 5,398 - 10,796 - General and administrative 64,466 62,078 134,839 112,451 Total $ 91,721 $ 62,078 $ 188,831 $ 112,451
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	2007 Share Incentive Plan Beginning Granted Exercised Canceled Ending Balance During During During Balance Outstanding Period Period Period Outstanding Exercisable Number of shares 220,000 - - (25,000 ) 195,000 195,000 Weighted average exercise price per share $ 12.56 - - $ 15.00 $ 12.24 $ 12.24 2016 Share Incentive Plan Beginning Granted Exercised Canceled Ending Balance During During During Balance Outstanding Period Period Period Outstanding Exercisable Number of shares 398,500 12,500 - (6,500 ) 404,500 102,500 Weighted average exercise price per share $ 4.43 $ 4.60 - $ 4.01 $ 4.44 $ 5.33
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Stock Price $ 4.60 Exercise Price $ 4.60 Dividend yield 0 % Expected volatility 68 % Risk-Free interest rate 1.79 % Expected life (in years) 6.00
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Intrinsic Number Exercise Intrinsic Price Range Outstanding Contractual Price Value Exercisable Price Value $4.00 - 7.00 384,500 8.8 $ 4.25 $ 0 82,500 $ 4.66 $ 0 $7.01 - 10.00 20,000 5.8 $ 8.07 $ 0 20,000 $ 8.07 $ 0 $10.01 - 12.00 120,000 4.7 $ 10.52 $ 0 120,000 $ 10.52 $ 0 $12.01 - 15.00 75,000 .2 $ 15.00 $ 0 75,000 $ 15.00 $ 0
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted Shares of Average Grant Restricted Date Fair Stock Units Value Unvested outstanding at December 31, 2021 5,500 $ 4.82 Granted - $ - Vested (5,500 ) $ 4.82 Forfeited/Cancelled - $ - - Unvested outstanding at June 30, 2022 - $ -

Note 10 - Earnings Per Share (T

Note 10 - Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Basic weighted average common shares outstanding 6,728,938 6,684,281 6,726,990 6,682,347 Dilutive effect of options and unvested restricted shares - 2,948 - - Diluted weighted average shares outstanding 6,728,938 6,687,229 6,726,990 6,682,347
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Stock Options 599,500 557,052 599,500 560,000 599,500 557,052 599,500 560,000

Note 11 - Segment Reporting (Ta

Note 11 - Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Eliminations* and 2022 CVD SDC Materials Unallocated Consolidated Assets $ 23,661 $ 8,474 $ 1,913 $ 68 $ 34,116 Revenue 3,782 1,591 816 (380 ) 5,809 Operating (loss) income (469 ) 227 143 (758 ) (857 ) Pretax (loss) income (451 ) 227 143 (758 ) (839 ) 2021 Assets $ 28,149 $ 6,765 $ 3,940 $ 66 $ 38,920 Revenue 1,804 1,162 1,087 (19 ) 4,034 Operating (loss) income (1,220 ) 368 503 (734 ) (1,083 ) Pretax (loss) income 1,209 368 628 (734 ) 1,471 Eliminations* and 2022 CVD SDC Materials Unallocated Consolidated Revenue 6,607 3,006 1,273 (425 ) 10,461 Operating (loss) income (1,236 ) 670 137 (1,438 ) (1,867 ) Pretax (loss) income (1,204 ) 670 136 (1.438 ) (1,836 ) 2021 Revenue 3,811 1,987 1,716 (114 ) 7,400 Operating (loss) income (1,753 ) 363 392 (1,704 ) (2,702 ) Pretax (loss) income 661 363 646 (1,704 ) (34 )

Note 3 - Concentration of Cre_2

Note 3 - Concentration of Credit Risk (Details Textual)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021	Jun. 30, 2022 USD ($)	Jun. 30, 2021	Dec. 31, 2021 USD ($)
Cash and Cash Equivalents, at Carrying Value, Total	$ 12,159,052		$ 12,159,052		$ 16,651,371
Cash Equivalents, at Carrying Value, Total	7,000,000		7,000,000		7,000,000
Cash, Uninsured Amount	$ 4,100,000		$ 4,100,000		$ 8,600,000
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Number Of Major Customers	2		2
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer A [Member]
Concentration Risk, Percentage	24.30%	17.30%	16.20%	18%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer B [Member]
Concentration Risk, Percentage	14.80%	12.90%	12.20%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer C [Member]
Concentration Risk, Percentage		11.20%
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Number Of Major Customers			3	1	2
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer A [Member]
Concentration Risk, Percentage			54.10%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customers [Member]
Concentration Risk, Percentage					50%

Note 4 - Revenue Disaggregati_3

Note 4 - Revenue Disaggregation (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Contract with Customer, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price and Input Costs	$ 12,800,000
Contract with Customer, Liability, Total	3,296,062
Transferred over Time [Member]
Contract with Customer, Liability, Total	$ 1,700,000	$ 6,000,000

Note 4 - Revenue Disaggregati_4

Note 4 - Revenue Disaggregation - Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net Revenue	$ 5,808,588	$ 4,034,408	$ 10,460,820	$ 7,400,268
Transferred over Time [Member]
Net Revenue	3,773,000	1,788,000	6,374,000	3,533,000
Transferred at Point in Time [Member]
Net Revenue	2,036,000	2,246,000	4,087,000	3,867,000
Aerospace [Member]
Net Revenue	520,000	774,000	1,221,000	1,488,000
Aerospace [Member] | Transferred over Time [Member]
Net Revenue	0	197,000	0	386,000
Aerospace [Member] | Transferred at Point in Time [Member]
Net Revenue	520,000	577,000	1,221,000	1,102,000
Energy, Storage and Transmission [Member]
Net Revenue	2,243,000	0	3,149,000	0
Energy, Storage and Transmission [Member] | Transferred over Time [Member]
Net Revenue	2,024,000	0	2,923,000	0
Energy, Storage and Transmission [Member] | Transferred at Point in Time [Member]
Net Revenue	219,000	0	226,000	0
Industrial [Member]
Net Revenue	2,175,000	2,519,000	4,043,000	4,564,000
Industrial [Member] | Transferred over Time [Member]
Net Revenue	1,450,000	1,226,000	2,446,000	2,595,000
Industrial [Member] | Transferred at Point in Time [Member]
Net Revenue	725,000	1,293,000	1,597,000	1,969,000
Research [Member]
Net Revenue	871,000	741,000	2,048,000	1,348,000
Research [Member] | Transferred over Time [Member]
Net Revenue	299,000	365,000	1,005,000	552,000
Research [Member] | Transferred at Point in Time [Member]
Net Revenue	$ 572,000	$ 376,000	$ 1,043,000	$ 796,000

Note 4 - Revenue Disaggregati_5

Note 4 - Revenue Disaggregation - Costs, Estimated Earnings, and Billings on Uncompleted Contracts (Details)	Jun. 30, 2022 USD ($)
Costs incurred on contracts in progress	$ 8,822,284
Estimated earnings	6,151,767
Costs and Estimated Earnings on Uncompleted Contracts	14,974,051
Billings to date	(13,683,261)
Net Cost in Excess of Billings	1,290,790
Deferred revenue related to non-systems contracts	(331,452)
Contract Liability In Excess of Contract Assets	959,338
Included in accompanying balance sheets
Contract assets	4,255,400
Contract liabilities	$ (3,296,062)

Note 5 - Inventories, Net - Com

Note 5 - Inventories, Net - Components of Inventories (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Raw materials	$ 1,366,405	$ 1,030,955
Work-in-process	684,000	194,060
Inventories	$ 2,050,405	$ 1,225,015

Note 6 - Accounts Receivable,_2

Note 6 - Accounts Receivable, Net (Details Textual) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 36,000	$ 59,000

Note 7 - Long-term Debt (Detail

Note 7 - Long-term Debt (Details Textual) - HSBC Bank Mortgage Loan [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Debt Instrument, Number of Payments	120
Debt Instrument, Periodic Payment, Total	$ 25,000
Long-term Debt, Total		$ 1,800,000
Debt Instrument, Interest Rate, Stated Percentage		1.86%
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate		1.75%
Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		0.50%

Note 8 - Stock-based Compensa_3

Note 8 - Stock-based Compensation Expense (Details Textual) - USD ($)		3 Months Ended			6 Months Ended
	Oct. 11, 2021	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-Based Payment Arrangement, Expense		$ 91,721		$ 62,078	$ 188,831	$ 112,451
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)					12,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)					$ 2.81
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)		599,500			599,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)		297,500			297,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)			0		0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)					0
Director [Member]
Share-Based Payment Arrangement, Expense	$ 40,000
Share-Based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)					4 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)					10 years
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 644,000			$ 644,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)					3 years
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 0			$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value					$ 3,458
Share-Based Payment Arrangement, Tranche One [Member] | Share-Based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					25%

Note 8 - Stock-based Compensa_4

Note 8 - Stock-based Compensation Expense - Compensation Expense (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Stock-based compensation	$ 91,721	$ 62,078	$ 188,831	$ 112,451
Cost of Revenue [Member]
Stock-based compensation	8,440	0	16,880	0
Research and Development Expense [Member]
Stock-based compensation	13,417	0	26,316	0
Selling and Shipping [Member]
Stock-based compensation	5,398	0	10,796	0
General and Administrative [Member]
Stock-based compensation	$ 64,466	$ 62,078	$ 134,839	$ 112,451

Note 8 - Stock-based Compensa_5

Note 8 - Stock-based Compensation Expense - Stock Option Plan (Details) - $ / shares	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Jun. 30, 2022
Granted during period (in shares)		12,500
Exercised during period (in shares)	0	0
Ending balance, number outstanding (in shares)		599,500
Number of shares exercisable (in shares)		297,500
The 2007 Share Incentive Plan [Member]
Beginning balance, number outstanding (in shares)	220,000	220,000
Granted during period (in shares)		0
Exercised during period (in shares)		0
Canceled during period (in shares)		(25,000)
Ending balance, number outstanding (in shares)		195,000
Number of shares exercisable (in shares)		195,000
Beginning balance, weighted average exercise price (in dollars per share)	$ 12.56	$ 12.56
Granted during period, weighted average exercise price (in dollars per share)		0
Exercised during period, weighted average exercise price (in dollars per share)		0
Canceled during period, weighted average exercise price (in dollars per share)		15
Ending balance, weighted average exercise price (in dollars per share)		12.24
Number of options exercisable, weighted average exercise price (in dollars per share)		$ 12.24
The 2016 Share Incentive Plan [Member]
Beginning balance, number outstanding (in shares)	398,500	398,500
Granted during period (in shares)		12,500
Exercised during period (in shares)		0
Canceled during period (in shares)		(6,500)
Ending balance, number outstanding (in shares)		404,500
Number of shares exercisable (in shares)		102,500
Beginning balance, weighted average exercise price (in dollars per share)	$ 4.43	$ 4.43
Granted during period, weighted average exercise price (in dollars per share)		4.60
Exercised during period, weighted average exercise price (in dollars per share)		0
Canceled during period, weighted average exercise price (in dollars per share)		4.01
Ending balance, weighted average exercise price (in dollars per share)		4.44
Number of options exercisable, weighted average exercise price (in dollars per share)		$ 5.33

Note 8 - Stock-based Compensa_6

Note 8 - Stock-based Compensation Expense - Assumptions (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares
Stock Price (in dollars per share)	$ 4.60
Exercise Price (in dollars per share)	$ 4.60
Dividend yield	0%
Expected volatility	68%
Risk-Free interest rate	1.79%
Expected life (in years) (Year)	6 years

Note 8 - Stock-based Compensa_7

Note 8 - Stock-based Compensation Expense - Outstanding and Exercisable Options (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares
Exercise Price Range 1 [Member]
Exercise price range, lower limit (in dollars per share)	$ 4
Exercise price range, upper limit (in dollars per share)	$ 7
Number of options outstanding (in shares) | shares	384,500
Number of options outstanding, weighted average remaining contractual term (Year)	8 years 9 months 18 days
Number of options outstanding, weighted average exercise price (in dollars per share)	$ 4.25
Number of options outstanding, intrinsic value | $	$ 0
Number of options exercisable (in shares) | shares	82,500
Number of options exercisable, weighted average exercise price (in dollars per share)	$ 4.66
Number of options exercisable, intrinsic value | $	$ 0
Exercise Price Range 2 [Member]
Exercise price range, lower limit (in dollars per share)	$ 7.01
Exercise price range, upper limit (in dollars per share)	$ 10
Number of options outstanding (in shares) | shares	20,000
Number of options outstanding, weighted average remaining contractual term (Year)	5 years 9 months 18 days
Number of options outstanding, weighted average exercise price (in dollars per share)	$ 8.07
Number of options outstanding, intrinsic value | $	$ 0
Number of options exercisable (in shares) | shares	20,000
Number of options exercisable, weighted average exercise price (in dollars per share)	$ 8.07
Number of options exercisable, intrinsic value | $	$ 0
Exercise Price Range 3 [Member]
Exercise price range, lower limit (in dollars per share)	$ 10.01
Exercise price range, upper limit (in dollars per share)	$ 12
Number of options outstanding (in shares) | shares	120,000
Number of options outstanding, weighted average remaining contractual term (Year)	4 years 8 months 12 days
Number of options outstanding, weighted average exercise price (in dollars per share)	$ 10.52
Number of options outstanding, intrinsic value | $	$ 0
Number of options exercisable (in shares) | shares	120,000
Number of options exercisable, weighted average exercise price (in dollars per share)	$ 10.52
Number of options exercisable, intrinsic value | $	$ 0
Exercise Price Range 4 [Member]
Exercise price range, lower limit (in dollars per share)	$ 12.01
Exercise price range, upper limit (in dollars per share)	$ 15
Number of options outstanding (in shares) | shares	75,000
Number of options outstanding, weighted average remaining contractual term (Year)	2 months 12 days
Number of options outstanding, weighted average exercise price (in dollars per share)	$ 15
Number of options outstanding, intrinsic value | $	$ 0
Number of options exercisable (in shares) | shares	75,000
Number of options exercisable, weighted average exercise price (in dollars per share)	$ 15
Number of options exercisable, intrinsic value | $	$ 0

Note 8 - Stock-based Compensa_8

Note 8 - Stock-based Compensation Expense - Restricted Stock and Restricted Stock Units Activity (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Granted (in shares)	0
Restricted Stock [Member]
Unvested outstanding at beginning of period (in shares)	5,500
Unvested outstanding at beginning of period, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.82
Granted (in shares)	0
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Vested (in shares)	(5,500)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.82
Forfeited/Cancelled (in shares)	0
Unvested outstanding at end of period (in shares)	0
Unvested outstanding at beginning of period, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0

Note 9 - Income Taxes (Details

Note 9 - Income Taxes (Details Textual) - USD ($) $ in Millions	Dec. 31, 2021	Mar. 27, 2020
Income Taxes Receivable	$ 7	$ 1.5

Note 10 - Earnings Per Share (D

Note 10 - Earnings Per Share (Details Textual)	Jun. 30, 2022 shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)	599,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)	297,500

Note 10 - Earnings Per Share -

Note 10 - Earnings Per Share - Calculation of Basic and Diluted Weighted Average Common Shares (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Basic weighted average common shares outstanding (in shares)	6,728,938	6,684,281	6,726,990	6,682,347
Dilutive effect of options and unvested restricted shares (in shares)	0	2,948	0	0
Diluted weighted average shares outstanding (in shares)	6,728,938	6,687,229	6,726,990	6,682,347

Note 10 - Earnings Per Share _2

Note 10 - Earnings Per Share - Anti-dilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Anti-dilutive securities (in shares)	599,500	557,052	599,500	560,000
Share-Based Payment Arrangement, Option [Member]
Anti-dilutive securities (in shares)	599,500	557,052	599,500	560,000

Note 11 - Segment Reporting (De

Note 11 - Segment Reporting (Details Textual)	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Number of Operating Segments			3
Revenue from Contract with Customer, Including Assessed Tax	$ 5,808,588	$ 4,034,408	$ 10,460,820	$ 7,400,268
Intersegment Eliminations [Member]
Revenue from Contract with Customer, Including Assessed Tax	(380,000)	(19,000)	(425,000)	(114,000)
SDC [Member] | Intersegment Eliminations [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 400,000	$ 20,000	$ 400,000	$ 100,000

Note 11 - Segment Reporting - S

Note 11 - Segment Reporting - Segment Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Assets	$ 34,115,515	$ 38,920,000	$ 34,115,515	$ 38,920,000	$ 35,524,229
Revenue from Contract with Customer, Including Assessed Tax	5,808,588	4,034,408	10,460,820	7,400,268
Operating (loss) income	(856,845)	(1,082,924)	(1,867,123)	(2,701,711)
Pretax (loss) income	(838,577)	1,471,489	(1,835,917)	(34,061)
Segment Reconciling Items [Member]
Assets	68,000	66,000	68,000	66,000
Intersegment Eliminations [Member]
Revenue from Contract with Customer, Including Assessed Tax	(380,000)	(19,000)	(425,000)	(114,000)
Operating (loss) income	(758,000)	(734,000)	(1,438,000)	(1,704,000)
Pretax (loss) income	(758,000)	(734,000)	(1,438)	(1,704,000)
CVD [Member] | Operating Segments [Member]
Assets	23,661,000	28,149,000	23,661,000	28,149,000
Revenue from Contract with Customer, Including Assessed Tax	3,782,000	1,804,000	6,607,000	3,811,000
Operating (loss) income	(469,000)	(1,220,000)	(1,236,000)	(1,753,000)
Pretax (loss) income	(451,000)	1,209,000	(1,204,000)	661,000
SDC [Member] | Operating Segments [Member]
Assets	8,474,000	6,765,000	8,474,000	6,765,000
Revenue from Contract with Customer, Including Assessed Tax	1,591,000	1,162,000	3,006,000	1,987,000
Operating (loss) income	227,000	368,000	670,000	363,000
Pretax (loss) income	227,000	368,000	670,000	363,000
SDC [Member] | Intersegment Eliminations [Member]
Revenue from Contract with Customer, Including Assessed Tax	400,000	20,000	400,000	100,000
Materials [Member] | Operating Segments [Member]
Assets	1,913,000	3,940,000	1,913,000	3,940,000
Revenue from Contract with Customer, Including Assessed Tax	816,000	1,087,000	1,273,000	1,716,000
Operating (loss) income	143,000	503,000	137,000	392,000
Pretax (loss) income	$ 143,000	$ 628,000	$ 136,000	$ 646,000